Dr. Lal Path Labs Ltd. — Updates, 24-07-2026: Press Release
24-07-2026 | 02:11 pm
24-07-2026 | 02:11 pm
Dr Lal PathLabs reported Q1 FY27 revenue of Rs 798 Cr (+19.1%) and PAT of Rs 170 Cr (+27.2%). Declared Rs 5 interim dividend. Strategic acquisitions include 80% of Sunshine Healthcare, Ghana (diagnostic business) and 30% of Neuome Technologies (innovative solutions).
No comments yet. Be the first to comment!
